Experience and outcome of 3 years of a European EQA scheme for genetic testing of the spinocerebellar ataxias

European Journal of Human Genetics

Volumn 16, Issue 8, 2008, Pages 913-920

  Seneca, Sara ^a   Morris, Michael A ^b   Patton, Simon ^c   Elles, Rob ^c   Sequeiros, Jorge ^d  

^a UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

^b UNIVERSITY HOSPITAL   (Switzerland)

^c ST MARY S HOSPITAL   (United Kingdom)

^d UNIVERSITY OF PORTO   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

AGAR GEL ELECTROPHORESIS; ALLELE; ARTICLE; CLINICAL LABORATORY; CLINICAL PROTOCOL; DATA ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; DIAGNOSTIC PROCEDURE; EUROPE; GENE LOCUS; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC SCREENING; GENOTYPE; GOOD LABORATORY PRACTICE; HUMAN; LABORATORY DIAGNOSIS; POLYACRYLAMIDE GEL ELECTROPHORESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUALITY CONTROL; SEQUENCE ANALYSIS; SILVER STAINING; SPINOCEREBELLAR DEGENERATION; STANDARD; TRINUCLEOTIDE REPEAT;

DNA; EUROPE; GENETIC SCREENING; GENOTYPE; HUMANS; LABORATORIES; MOLECULAR DIAGNOSTIC TECHNIQUES; MUTATION; QUALITY ASSURANCE, HEALTH CARE; QUALITY CONTROL; SPINOCEREBELLAR ATAXIAS; TRINUCLEOTIDE REPEATS;

EID: 48249128741     PISSN: 10184813     EISSN: 14765438     Source Type: Journal    
DOI: 10.1038/ejhg.2008.29     Document Type: Article

References (34)

1. Sequeiros J, Martins S, Silveira I: Epidemiology and population genetics of inherited ataxias; in Subramony SH, Dürr A (eds): Handbook of Clinical Neurology, Ataxic Disorders. Amsterdam: Elsevier (in press).
2. Libeer JC: Role of external quality assurance schemes in assessing and improving quality in medical laboratories. Clin Chim Acta 2001; 309: 173-177.
3. Losekoot M, Bakker B, Laccone F, Stenhouse S, Elles R: A European pilot quality assessment scheme for molecular diagnosis of Huntington's disease. Eur J Med Genet 1999; 7: 217-222.
4. Dequeker E, Ramsden S, Gordy W, Stenzel T, Barton D: Quality control in molecular, genetic testing. Nat Rev Genet 2001; 2: 717-723.
5. Mueller CR, Kristoffersson U, Stoppa-Lyonnet D: External quality assessment for mutation detection in the BRCA1 and BRCA2 genes: EMQN's experience of 3 years. Ann Oncol 2004; 15 (Suppl 1): I14-i17.
6. Hertzberg M, Neville S, Favaloro E, McDonald D: External quality assurance of DNA testing for thrombophilia mutations. Am J Clin Pathol 2005; 123: 189-193.
7. Hertzberg M, Neville S, McDonald D: External quality assurance of molecular analysis of haemochromatosis gene mutations. J Clin Pathol 2006; 59: 744-747.
8. Ramsden S, Deans Z, Robinson D et al: Monitoring standards for molecular genetic testing in the United Kingdom, The Netherlands, and Ireland. Genet Test 2006; 10: 147-156.
9. Orr HT, Chung MY, Banfi S, Schwinger E, Bark K: Expansion of an unstable trinucleotide CAG repeat in spinocerebellar ataxia type 1. Nat Genet 1993; 4: 221-226.
10. Zühlke C, Dalski A, Hellenbroich Y, Bubel S, Schwinger E, Burk K: Spinocerebellar ataxia type 1 (SCA1): Phenotype-genotype correlation studies in intermediate alleles. Eur J Hum Genet 2002; 10: 204-209.
11. Koide R, Ikeuchi T, Onodera O et al: Unstable expansion of CAG repeat in hereditary dentatorubral-pallidoluysian atrophy (DRPLA). Nat Genet. 1994; 6: 9-13.
12. Nagafuchi S, Yanagisawa H, Sato K et al: Dentatorubral and pallidoluysian atrophy expansion of an unstable CAG trinucleotide on chromosome 12p. Nat Genet 1994; 6: 14-18.
13. Imbert G, Saudou F, Yvert G et al: Cloning of the gene for spinocerebellar ataxia 2 reveals a locus with high sensitivity to expanded CAG/glutamine repeats. Nat Genet 1996; 14: 285-291.
14. Pulst S-M, Nechiporuk A, Nechiporuk T et al: Moderate expansion of normally biallelic trinucleotide repeat in spinocerebellar ataxia type 2. Nat Genet 1996; 14: 269-275.
15. Sanpei K, Takano H, Igarashi S et al: Identification of the spinocerebellar ataxia type 2 gene using a direct identification of repeat expansion and cloning technique, DIRECT. Nat Genet 1996; 14: 277-283.
16. Silveira I, Miranda C, Guimarães L et al: Trinucleotide repeats in 202 families with ataxia: A small expanded (CAG)n allele at the SCA17 locus. Arch Neurol 2002; 59: 623-629.
17. Maciel P, Gaspar C, DeStefano AL et al: Correlation between CAG repeat length and clinical features in Machado-Joseph disease. Am J Hum Genet 1995; 57: 54-61.
18. Maciel P, Costa MC, Ferro A et al: Improvement in the molecular diagnosis of Machado-Joseph disease. Arch Neurol 2001; 58: 1821-1827.
19. Takiyama Y, Sakoe K, Nakano I, Nishizawa M: Machado-Joseph disease: cerebellar ataxia and autonomic dysfunction in a patient with the shortest known expanded allele (56 CAG repeat units) of the MJD1 gene. Neurology 1997; 49: 604-606.
20. Padiath QS, Srivastava AK, Roy S, Jain S, Brahmachari SK: Identification of a novel 45 repeat unstable allele associated with a disease phenotype at the MJD1/SCA3 locus. Am J Med Genet B 2005; 133: 124-126.
21. Zhuchenko O, Bailey J, Bonnen P et al: Autosomal dominant cerebellar ataxia (SCA6) associated with small polyglutamine expansions in the alpha 1A-voltage-dependent calcium channel. Nat Genet 1997; 15: 62-69.
22. David G, Abbas N, Stevanin G et al: Cloning of the SCA7 gene reveals a highly unstable CAG repeat expansion. Nat Genet 1997; 17: 65-70.
23. Stevanin G, Giunti P, David G et al: De novo expansion of intermediate alleles in spinocerebellar ataxia type 7. Hum Mol Genet 1998; 11: 1809-1813.
24. Koob MD, Moseley ML, Schut LJ et al: An untranslated CTG expansion causes a novel form of spinocerebellar ataxia (SCA8). Nat Genet 1999; 21: 379-384.
25. Matsuura T, Yamagata T, Burgess DL et al: Large expansion of the ATTCT pentanucleotide repeat in spinocerebellar ataxia type 10. Nat Genet 2000; 26: 191-194.
26. Alonso I, Jardim LB, Artigalas O et al: Reduced penetrance of intermediate size alleles in spinocerebellar ataxia type 10. Neurology 2006; 66: 1602-1604.
27. Holmes SE, O'Hearn EE, McInnis MG et al: Expansion of a novel CAG trinucleotide repeat in the 5′ region of PPP2R2B is associated with SCA12. Nat Genet 1999; 23: 391-392.
28. Zühlke C, Gehlken U, Hellenbroich Y, Schwinger E, Burk E: Phenotypical variability of expanded alleles in the TATA-binding protein gene. Reduced penetrance in SCA17? J Neurol 2003; 250: 161-163.
29. Oda M, Maruyama H, Komure O et al: Possible reduced penetrance of expansion of 44 to 47 CAG/CAA repeats in the TATA-binding protein gene in spinocerebellar ataxia type 17. Arch Neurol 2004; 61: 209-212.
30. Kawaguchi Y, Okamoto T, Taniwaki M et al: CAG expansions in a novel gene for Machado - Joseph disease at chromosome 14q32.1. Nat Genet 1994; 8: 221-222.
31. Dequeker E, Cassiman JJ: Evaluation of CFTR gene mutation testing methods in 136 diagnostic laboratories: Report of a large European external quality assessment. Eur J Hum Genet 1998; 6: 165-175.
32. Noll WW, Belloni DR, Stenzel T, Gordy WW: HFE C282Y heterozygote with intron 4 (5569A) polymorphism was correctly genotyped by all 67 laboratories in a nationwide ACMG/CAP molecular genetics proficiency survey. Nat Genet 1999; 23: 271-272.
33. Lutz CT, Foster PA, Noll WW et al: Multicenter evaluation of PCR methods for the detection of factor V Leiden (R506Q) genotypes. Clin Chem 1998; 44: 1356-1358.
34. Warner JP, Barron LH, Goudie D et al: A general method for the detection of large CAG repeat expansions by fluorescent PCR. J Med Genet 1996; 33: 1022-1026.